Adicet Bio Inc (ACET)

$7.89 -0.23 (-2.83%)
Market Cap 75.91M
Revenue (ttm) 0.00
Net Income (ttm) -116.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 74,900
Avg Vol 98,046
Day's Range N/A - N/A
Shares Out 9.35M
Stochastic %K 8%
Beta 1.58
Analysts Strong Sell
Price Target $34.83

Company Profile

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 503 9095
Address:
131 Dartmouth Street, 3rd Floor, Boston, United States
BioTechChap
BioTechChap Jul. 16 at 5:21 AM
$ACET FDA meeting minutes take up to 30 days, so we should expect an update before the end of the month latest. Assuming a combination of regulatory and data updates.
1 · Reply
metalcook
metalcook Jul. 15 at 8:08 AM
$ACET if it doesnt come this week, 6 Aug is more likely. Hope they close shop amd return money to shareholders
1 · Reply
rml360
rml360 Jul. 14 at 8:08 PM
$ACET where is the data? wtf? anyone know anything?
0 · Reply
onononon
onononon Jul. 11 at 2:32 AM
$ACET they'll probably release the data once july options expire.
0 · Reply
metalcook
metalcook Jul. 10 at 11:14 AM
$ACET there is alomst 0 volume. XBI is at all time highs. Something clearly wring here. Yes it is trading beneaty cash but bad management will burn cash fast. Market is expecting PR that will indicate stop CAR allogenic trials and begin phase 1 in prostate cancer which would validate the market price we are seeing now.
0 · Reply
AGC_Trader
AGC_Trader Jul. 9 at 1:52 PM
$ACET The $9.30 -$9.40 area is quite a resistance...I am curious to see what happens after it passes through it
2 · Reply
DCZ
DCZ Jul. 8 at 3:33 PM
$ACET everything is dumping today on my list except this. News leak?
0 · Reply
BioTechChap
BioTechChap Jul. 7 at 9:06 PM
$ACET
0 · Reply
metalcook
metalcook Jul. 6 at 10:53 AM
$ACET release$ACET of data should be doNE ASAP!
0 · Reply
thebrockettman
thebrockettman Jul. 2 at 10:38 PM
$ACET Idk what's happening but I like it! Above average volume most of this week! The 200d moving average is at $9.09 and we got so close to closing above that today. If we can stay above that the algos should start to participate too!
1 · Reply
Latest News on ACET
Adicet Bio Transcript: AGM 2026

Jun 17, 2026, 5:00 PM EDT - 4 weeks ago

Adicet Bio Transcript: AGM 2026

Adicet Bio Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 7:35 AM EDT - 6 weeks ago

Adicet Bio Transcript: Jefferies Global Healthcare Conference 2026

Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference

May 14, 2026, 4:00 PM EDT - 2 months ago

Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference

Adicet Bio reports Q1 EPS ($1.88), consensus ($3.08)

2026-05-13T20:24:33.000Z - 2 months ago

Adicet Bio reports Q1 EPS ($1.88), consensus ($3.08)

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

May 13, 2026, 4:01 PM EDT - 2 months ago

Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

Adicet Bio Earnings release: Q1 2026

May 13, 2026, 4:00 PM EDT - 2 months ago

Adicet Bio Earnings release: Q1 2026

Adicet Bio Quarterly report: Q1 2026

May 13, 2026, 4:00 PM EDT - 2 months ago

Adicet Bio Quarterly report: Q1 2026

Adicet Bio Slides: Investor presentation

May 13, 2026, 7:00 AM EDT - 2 months ago

Adicet Bio Slides: Investor presentation

Adicet Bio assumed with a Buy at Jefferies

2026-05-04T20:41:09.000Z - 2 months ago

Adicet Bio assumed with a Buy at Jefferies

Adicet Bio Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Adicet Bio Proxy statement: Proxy filing

Adicet Bio Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 2 months ago

Adicet Bio Proxy statement: Proxy filing

Adicet Bio price target lowered to $27 from $50 at H.C. Wainwright

2026-03-23T10:10:51.000Z - 4 months ago

Adicet Bio price target lowered to $27 from $50 at H.C. Wainwright

Adicet Bio price target lowered to $100 from $128 at Guggenheim

2026-03-13T11:40:50.000Z - 4 months ago

Adicet Bio price target lowered to $100 from $128 at Guggenheim

Adicet Bio files $250M mixed securities shelf

2026-03-12T21:20:37.000Z - 4 months ago

Adicet Bio files $250M mixed securities shelf

Adicet Bio Annual report: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 4 months ago

Adicet Bio Annual report: Q4 2025

Adicet Bio Earnings release: Q4 2025

Mar 12, 2026, 5:00 PM EDT - 4 months ago

Adicet Bio Earnings release: Q4 2025

Adicet Bio reports Q4 EPS ($2.94), consensus ($2.99)

2026-03-12T20:05:37.000Z - 4 months ago

Adicet Bio reports Q4 EPS ($2.94), consensus ($2.99)

Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

Mar 12, 2026, 4:00 PM EDT - 4 months ago

Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress

Adicet Bio Registration statement: Registration Filing

Mar 12, 2026, 8:00 AM EDT - 4 months ago

Adicet Bio Registration statement: Registration Filing

Adicet Bio Slides: Investor presentation

Mar 12, 2026, 7:00 AM EDT - 4 months ago

Adicet Bio Slides: Investor presentation

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Jan 30, 2026, 7:00 AM EST - 6 months ago

Adicet Bio to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026

Adicet Bio price target adjusted to $50 from $9 at H.C. Wainwright

2026-01-21T11:16:04.000Z - 6 months ago

Adicet Bio price target adjusted to $50 from $9 at H.C. Wainwright

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

Jan 7, 2026, 7:00 AM EST - 6 months ago

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

Adicet Bio price target lowered to $18 from $128 at Canaccord

2026-01-06T11:26:03.000Z - 6 months ago

Adicet Bio price target lowered to $18 from $128 at Canaccord

Adicet Bio trading halted, news pending

2025-12-30T00:55:17.000Z - 7 months ago

Adicet Bio trading halted, news pending

Adicet Bio Announces Reverse Stock Split

Dec 26, 2025, 8:30 AM EST - 7 months ago

Adicet Bio Announces Reverse Stock Split

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Nov 28, 2025, 2:23 PM EST - 8 months ago

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio Proxy statement: Proxy Filing

Nov 17, 2025, 7:00 AM EST - 8 months ago

Adicet Bio Proxy statement: Proxy Filing

Adicet Bio Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 11, 2025, 3:00 PM EST - 8 months ago

Adicet Bio Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Adicet Bio price target raised to $9 from $4 at H.C. Wainwright

2025-11-07T11:31:14.000Z - 9 months ago

Adicet Bio price target raised to $9 from $4 at H.C. Wainwright

Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 5, 2025, 4:01 PM EST - 9 months ago

Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates

Adicet Bio Earnings release: Q3 2025

Nov 5, 2025, 7:00 AM EST - 9 months ago

Adicet Bio Earnings release: Q3 2025

Adicet Bio Quarterly report: Q3 2025

Nov 5, 2025, 7:00 AM EST - 9 months ago

Adicet Bio Quarterly report: Q3 2025

Adicet Bio Proxy statement: Proxy Filing

Nov 5, 2025, 7:00 AM EST - 9 months ago

Adicet Bio Proxy statement: Proxy Filing

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Oct 31, 2025, 4:59 PM EDT - 9 months ago

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference

Oct 28, 2025, 7:00 AM EDT - 9 months ago

Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference

Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)

Oct 16, 2025, 7:00 AM EDT - 9 months ago

Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)

Adicet Bio Transcript: Study Update

Oct 7, 2025, 8:00 AM EDT - 10 months ago

Adicet Bio Transcript: Study Update

Adicet Bio Press release: Study Update

Oct 7, 2025, 8:00 AM EDT - 10 months ago

Adicet Bio Press release: Study Update

Adicet Bio Slides: Study Update

Oct 7, 2025, 8:00 AM EDT - 10 months ago

Adicet Bio Slides: Study Update

Adicet Bio, Inc. Announces $80 Million Registered Direct Offering

Oct 7, 2025, 7:01 AM EDT - 10 months ago

Adicet Bio, Inc. Announces $80 Million Registered Direct Offering

Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Oct 7, 2025, 6:45 AM EDT - 10 months ago

Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)

Adicet Bio Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 4:30 PM EDT - 11 months ago

Adicet Bio Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 7:00 AM EDT - 11 months ago

Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Adicet Bio Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Aug 12, 2025, 1:30 PM EDT - 1 year ago

Adicet Bio Transcript: Canaccord Genuity’s 45th Annual Growth Conference

Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025, 4:01 PM EDT - 1 year ago

Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Adicet Bio Earnings release: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio Earnings release: Q2 2025

Adicet Bio Quarterly report: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio Quarterly report: Q2 2025

Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference

Aug 5, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference

Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

Jul 24, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

Adicet Bio Slides: Investor Presentation

Jun 5, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio Slides: Investor Presentation

Adicet Bio Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 4:20 PM EDT - 1 year ago

Adicet Bio Transcript: Jefferies Global Healthcare Conference 2025

Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference

May 21, 2025, 4:00 PM EDT - 1 year ago

Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference

Adicet Bio Transcript: The Citizens JMP Life Sciences Conference 2025

May 7, 2025, 1:30 PM EDT - 1 year ago

Adicet Bio Transcript: The Citizens JMP Life Sciences Conference 2025

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

May 6, 2025, 4:01 PM EDT - 1 year ago

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

Adicet Bio Quarterly report: Q1 2025

May 6, 2025, 4:00 PM EDT - 1 year ago

Adicet Bio Quarterly report: Q1 2025

Adicet Bio Earnings release: Q1 2025

May 6, 2025, 4:00 PM EDT - 1 year ago

Adicet Bio Earnings release: Q1 2025

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference

Apr 30, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference

Adicet Bio Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Adicet Bio Proxy statement: Proxy Filing

Adicet Bio Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Adicet Bio Proxy statement: Proxy Filing

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Adicet Bio Appoints Michael Grissinger to the Board of Directors

Apr 17, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio Appoints Michael Grissinger to the Board of Directors

Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 31, 2025, 5:12 PM EDT - 1 year ago

Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference

Mar 31, 2025, 7:00 AM EDT - 1 year ago

Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Mar 6, 2025, 4:01 PM EST - 1 year ago

Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress

Adicet Bio Annual report: Q4 2024

Mar 6, 2025, 3:00 PM EST - 1 year ago

Adicet Bio Annual report: Q4 2024

Adicet Bio Earnings release: Q4 2024

Mar 6, 2025, 3:00 PM EST - 1 year ago

Adicet Bio Earnings release: Q4 2024

Adicet Bio Registration statement: Registration Filing

Mar 6, 2025, 7:00 AM EST - 1 year ago

Adicet Bio Registration statement: Registration Filing

Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

Mar 3, 2025, 7:00 AM EST - 1 year ago

Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

Feb 27, 2025, 7:00 AM EST - 1 year ago

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)

Adicet Bio Transcript: Guggenheim SMID Cap Biotech Conference

Feb 5, 2025, 2:00 PM EST - 1 year ago

Adicet Bio Transcript: Guggenheim SMID Cap Biotech Conference

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement

Feb 5, 2025, 7:10 AM EST - 1 year ago

Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Jan 29, 2025, 7:00 AM EST - 1 year ago

Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

Jan 8, 2025, 4:10 PM EST - 1 year ago

Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Dec 19, 2024, 7:00 AM EST - 1 year ago

Adicet Bio Announces First Patient Dosed in the Phase 1 Clinical Trial of ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

Dec 18, 2024, 7:00 AM EST - 1 year ago

Adicet Bio Appoints Julie Maltzman, M.D. as Chief Medical Officer

Adicet Bio Transcript: Jefferies London Healthcare Conference 2024

Nov 19, 2024, 7:30 AM EST - 1 year ago

Adicet Bio Transcript: Jefferies London Healthcare Conference 2024

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Nov 18, 2024, 4:00 PM EST - 1 year ago

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

Nov 18, 2024, 7:00 AM EST - 1 year ago

Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024

Nov 16, 2024, 9:00 AM EST - 1 year ago

Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024

Adicet Bio Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Nov 12, 2024, 3:00 PM EST - 1 year ago

Adicet Bio Transcript: Guggenheim Securities Inaugural Healthcare Innovation Conference

Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 6, 2024, 4:00 PM EST - 1 year ago

Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates

Adicet Bio Quarterly report: Q3 2024

Nov 5, 2024, 6:00 PM EST - 1 year ago

Adicet Bio Quarterly report: Q3 2024

Adicet Bio Earnings release: Q3 2024

Nov 5, 2024, 6:00 PM EST - 1 year ago

Adicet Bio Earnings release: Q3 2024

Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024

Nov 5, 2024, 7:00 AM EST - 1 year ago

Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024

Adicet Bio to Participate in Upcoming Investor Conferences

Nov 1, 2024, 7:00 AM EDT - 1 year ago

Adicet Bio to Participate in Upcoming Investor Conferences

Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome

Adicet Bio to Present at the American Society of Gene & Cell Therapy's (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference

Sep 30, 2024, 4:30 PM EDT - 1 year ago

Adicet Bio to Present at the American Society of Gene & Cell Therapy's (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference

Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases

Sep 30, 2024, 7:00 AM EDT - 1 year ago

Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases

ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue

Sep 19, 2024, 7:00 AM EDT - 1 year ago

ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue

Adicet Bio Transcript: 9th Annual CAR-TCR U.S. Summit

Sep 18, 2024, 8:00 PM EDT - 1 year ago

Adicet Bio Transcript: 9th Annual CAR-TCR U.S. Summit

Adicet Bio Slides: 9th Annual CAR-TCR U.S. Summit

Sep 18, 2024, 8:00 PM EDT - 1 year ago

Adicet Bio Slides: 9th Annual CAR-TCR U.S. Summit

Adicet Bio Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 10, 2024, 2:30 PM EDT - 2 years ago

Adicet Bio Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 4:00 PM EDT - 2 years ago

Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors

Aug 19, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors

Adicet Bio Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Aug 13, 2024, 10:30 AM EDT - 2 years ago

Adicet Bio Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Adicet Bio Slides: FY 2024

Aug 13, 2024, 10:30 AM EDT - 2 years ago

Adicet Bio Slides: FY 2024

Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates

Adicet Bio Quarterly report: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio Quarterly report: Q2 2024

Adicet Bio Earnings release: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio Earnings release: Q2 2024

Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Jul 8, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma

Jun 24, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma

Adicet Bio Transcript: Jefferies 2024 Global Healthcare Conference

Jun 5, 2024, 1:00 PM EDT - 2 years ago

Adicet Bio Transcript: Jefferies 2024 Global Healthcare Conference

Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis

Jun 5, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis

Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference

May 29, 2024, 7:00 AM EDT - 2 years ago

Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference

Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates

May 14, 2024, 4:01 PM EDT - 2 years ago

Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates

BioTechChap
BioTechChap Jul. 16 at 5:21 AM
$ACET FDA meeting minutes take up to 30 days, so we should expect an update before the end of the month latest. Assuming a combination of regulatory and data updates.
1 · Reply
metalcook
metalcook Jul. 15 at 8:08 AM
$ACET if it doesnt come this week, 6 Aug is more likely. Hope they close shop amd return money to shareholders
1 · Reply
rml360
rml360 Jul. 14 at 8:08 PM
$ACET where is the data? wtf? anyone know anything?
0 · Reply
onononon
onononon Jul. 11 at 2:32 AM
$ACET they'll probably release the data once july options expire.
0 · Reply
metalcook
metalcook Jul. 10 at 11:14 AM
$ACET there is alomst 0 volume. XBI is at all time highs. Something clearly wring here. Yes it is trading beneaty cash but bad management will burn cash fast. Market is expecting PR that will indicate stop CAR allogenic trials and begin phase 1 in prostate cancer which would validate the market price we are seeing now.
0 · Reply
AGC_Trader
AGC_Trader Jul. 9 at 1:52 PM
$ACET The $9.30 -$9.40 area is quite a resistance...I am curious to see what happens after it passes through it
2 · Reply
DCZ
DCZ Jul. 8 at 3:33 PM
$ACET everything is dumping today on my list except this. News leak?
0 · Reply
BioTechChap
BioTechChap Jul. 7 at 9:06 PM
$ACET
0 · Reply
metalcook
metalcook Jul. 6 at 10:53 AM
$ACET release$ACET of data should be doNE ASAP!
0 · Reply
thebrockettman
thebrockettman Jul. 2 at 10:38 PM
$ACET Idk what's happening but I like it! Above average volume most of this week! The 200d moving average is at $9.09 and we got so close to closing above that today. If we can stay above that the algos should start to participate too!
1 · Reply
AGC_Trader
AGC_Trader Jul. 2 at 2:14 PM
$ACET Something is moving...
0 · Reply
tr1llA
tr1llA Jun. 30 at 3:40 PM
$ACET volume already around 75k this morning, something’s happenin soon
0 · Reply
BioTechChap
BioTechChap Jun. 29 at 8:17 PM
$ACET Throwing LN/SSc data and regulatory updates all in one massive corporate update this week. Better be a good one - GL folks
1 · Reply
tr1llA
tr1llA Jun. 26 at 8:58 PM
$ACET feelin like any day now for news! This is such a binary play. If good data, shoot up, if bad, big down.
0 · Reply
DCZ
DCZ Jun. 25 at 10:33 AM
$ACET someone really likes to play games here with low volume in the pre-market
2 · Reply
metalcook
metalcook Jun. 23 at 8:14 AM
$ACET what a joke. Something is clearly wrong here or else it would trade at half cash value. Close shop and return money. Cant RA force them?
1 · Reply
skyman
skyman Jun. 12 at 5:00 PM
$ACET Some calls bet on news being released next week it looks like. We'll see:
0 · Reply
WARBUD
WARBUD Jun. 9 at 11:54 AM
$ACET 🐂
0 · Reply
MarketBeat
MarketBeat Jun. 4 at 6:05 PM
https://marketbeat.com/a/8692882/ $ACET Adicet Bio Teases Autoimmune Data Catalysts, PSMA Plans at Jefferies Conference
0 · Reply
ZoooLander
ZoooLander Jun. 4 at 1:11 AM
$ACET they said they will be releasing their stage 1 clinical trial results in the first half of this year and Chen Shor is doing a fireside chat tomorrow morning at Jefferies global healthcare conference. Only 4 weeks left to make their deadline so what a perfect stage to release their results. At 7:35 ET is when it's set to start so when the markets open well either see it crash or rocket.
1 · Reply
UnicornChaser
UnicornChaser Jun. 1 at 12:04 PM
$ACET
0 · Reply
DCZ
DCZ May. 27 at 5:45 PM
$ACET hopefully one day soon we will wake up and they will have released awesome trial results and this thing will be up 100-200+% and will be trending with a bunch of mindless pumpers/day traders suddenly showing up to drive the price up.
2 · Reply